CGT

33개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved33 programs
CGTLimited DatastaleSichuan UniversityPhase 1

Dual-targeting VEGFR1 and PD-L1 CAR-T cells (Dual-targeting VEGFR1 and PD-L1 CAR-T cells)

Malignant Peritoneal Effusion; Malignant Ascites · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleSichuan UniversityPhase 1

Dual-targeting VEGFR1/PD-L1 CAR-T cells (Dual-targeting VEGFR1/PD-L1 CAR-T cells)

Malignant Peritoneal Effusion; Malignant Ascites · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBeijing BiotechPhase 2

EB-MF-CAR-NK-01 (EB-MF-CAR-NK-01)

Malignant Pleural Mesotheliomas · Malignant Pleural Mesotheliomas

#MalignantPleuralMesotheliomas#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleAffiliated Hospital of Jiangnan…Phase 1

IFN-γ and CIK cells, Tcm cells or CAR T cells (IFN-γ and CIK cells, Tcm cells or CAR T cells)

Pleural Effusion, Malignant · Pleural Effusion, Malignant

#PleuralEffusionMalignant#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleMing YangPhase 1

IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody (IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody)

Recurrent Malignant Glioma · PD-L1

#PD-L1#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleCancer Institute and Hospital, …Phase 2

Meta10-TIL (Meta10-TIL)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleWest China HospitalPhase 1

Oncolytic Virus SDJ001 (Oncolytic Virus SDJ001)

Malignant Tumor · Malignant Tumor

#MalignantTumor#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleWest China HospitalPhase 1

Oncolytic Virus YD06-1 (Oncolytic Virus YD06-1)

Malignant Tumor · Malignant Tumor

#MalignantTumor#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleFred Hutchinson Cancer CenterPhase 1

ROR1 CAR-specific Autologous T-Lymphocytes (ROR1 CAR-specific Autologous T-Lymphocytes)

Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
CGTLimited DatastalePeking UniversityPhase 1

ScTIL injection and B lymphocytes adjuvant (ScTIL injection and B lymphocytes adjuvant)

Digestive System Malignant Solid Tumors · Digestive System Malignant Solid Tumors

#DigestiveSystemMalignantSolidTum#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

T cells modified with RNA anti -cMET CAR (T cells modified with RNA anti -cMET CAR)

Malignant Melanoma; Breast Cancer · Malignant Melanoma

#MalignantMelanoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
CGTLimited DatastaleInnovative Cellular Therapeutic…Preclinical

gucy2c cart cells (gucy2c cart cells)

Malignant Neoplasms of Digestive Organs · Malignant Neoplasms of Digestive Organs

#MalignantNeoplasmsofDigestiveOrg#CGT#Preclinical#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleShenzhen SiBiono GeneTech Co.,L…Approved

p53 gene therapy (p53 gene therapy)

Advanced Malignant Thyroid Tumors · Advanced Malignant Thyroid Tumors

#AdvancedMalignantThyroidTumors#CGT#Approved#cell-gene-therapy#CAR-T+2
Trials 1Status Active

2 / 2 pages

← PreviousNext →